Literature DB >> 6403279

Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patients.

D R Blake, A Blann, P A Bacon, M Farr, J M Gutteridge, B Halliwell.   

Abstract

1. The protein caeruloplasmin inhibits certain free radical reactions, in part probably due to its ability to oxidize Fe2+ into Fe3+ (ferroxidase activity). Since caeruloplasmin is present in synovial fluid from rheumatoid patients, we investigated its properties in relation to protection of the joint from damage by oxygen radicals produced by activated phagocytes. 2. The ferroxidase and ascorbate oxidase activities of serum from both normal and rheumatoid patients could be accounted for by the caeruloplasmin present, as determined immunologically. More caeruloplasmin is present in the serum of rheumatoid patients than in normal serum. 3. Synovial fluid from rheumatoid patients contains caeruloplasmin protein but its ferroxidase and ascorbate oxidase activities are abnormally low. It is suggested that ferroxidase deficiency contributes to radical damage in the rheumatoid joint.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403279     DOI: 10.1042/cs0640551

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Caeruloplasmin concentration and oxidase activity in polyarthritis.

Authors:  J S Dixon; M Greenwood; J R Lowe
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

2.  The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper.

Authors:  J M Gutteridge; P G Winyard; D R Blake; J Lunec; S Brailsford; B Halliwell
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

3.  Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells.

Authors:  C Broadley; R L Hoover
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.